IN.PACT Admiral Drug Eluting Balloon

The IN.PACT Admiral drug eluting balloon (DEB) is a clinically-proven, primary endovascular therapy that enables physicians to confidently treat femoropopliteal disease, reduce reintervention, and preserve future treatment options.

  • Incomparable Clinical Outcomes in the SFA
    • IN.PACT Admiral demonstrates positive, consistent outcomes across a broad range of patient populations.
  • Proven Primary Therapy in SFA Disease
    • IN.PACT Admiral has demonstrated a low provisional stenting rate, minimizing the need for durable implants.
  • Differentiated DCB Design Intended to Maximize Safety and Efficacy
    • Proprietary balloon coating provides efficacy while maintaining clinical safety.
  • Lowest Reported Reintervention Rate Offers Best-in-Class Patient Outcomes while Reducing Healthcare System Costs

UC201301645c EE